Smith & Nephew (SNN) Cash & Equivalents Growth (5y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Smith & Nephew | 5.16 Bn | 4.58 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 16.73% |
| Jun 28, 2025 | -13.72% |
| Dec 31, 2024 | 19.22% |
| Dec 31, 2023 | -1.94% |
| Dec 31, 2022 | 17.69% |
| Dec 31, 2021 | 129.23% |
| Dec 31, 2020 | 20.30% |
| Jun 30, 2020 | 3.61% |
| Dec 31, 2019 | 31.64% |
| Dec 31, 2018 | 14.80% |
| Jun 30, 2018 | 65.76% |
| Dec 31, 2017 | -0.76% |
| Dec 31, 2016 | -27.90% |
| Dec 31, 2015 | -10.13% |
| Jun 30, 2015 | 46.74% |
| Dec 31, 2014 | 61.05% |
| Sep 30, 2014 | 0.65% |
| Mar 31, 2014 | -11.75% |